Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors

References

• Dajorath , J , Klein , TE , Lybrand , TP and Novotny , J . 1997 . Computer aided drug discovery: from target properties to drug candidates . Pac. Symp. Biocomputing , 4 : 413 – 414 .
   Google Scholar
• Prathaipati , P , Dixit , A and Saxena , AK . 2007 . Computer-aided drug design: integration of structure- based and ligand based approaches in drug design . Curr. Comput. Aided Drug Des. , 3 : 341 – 352 .
   Google Scholar
• Csermely , P , Schnaider , T , Soti , C , Prohaszka , Z and Nardai , G . 1998 . The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review . Pharmacol. Ther. , 79 : 129 – 168 .
   PubMed Web of Science ®Google Scholar
• Richter , K and Buchner , J . 2001 . Hsp90: chaperoning signal transduction . J. Cell. Physiol. , 188 : 281 – 290 .
   PubMed Web of Science ®Google Scholar
• Sharp , S and Workman , P . 2006 . Inhibitors of the Hsp90 molecular chaperone. Current status . Adv. Cancer Res. , 95 : 323 – 348 .
   PubMed Web of Science ®Google Scholar
• Neckers , L and Ivy , SP . 2003 . Heat shock protein 90 . Curr. Opin. Oncol. , 15 : 419 – 424 .
   PubMed Web of Science ®Google Scholar
• Fortugno , P , Beltrami , E , Plescia , J , Fontana , J , Pradhan , D , Marchisio , PC , Sessa , WC and Altieri , DC . 2003 . Regulation of survivin function by Hsp90 . Proc. Natl. Acad. Sci. USA , 100 : 13791 – 13796 .
   PubMed Web of Science ®Google Scholar
• Marcu , MG , Schulte , TW and Neckers , LJ . 2000 . Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins . Natl. Cancer Inst. , 92 : 242 – 248 .
   Google Scholar
• Chiosis , G , Vilenchik , M , Kim , J and Solit , D . 2004 . Hsp90: the vulnerable chaperone . Drug Discov. Today , 9 : 881 – 888 .
   PubMed Web of Science ®Google Scholar
• Janin , YL . 2005 . Heat shock protein 90 inhibitors . J. Med. Chem. , 48 : 7503 – 7512 .
   PubMed Web of Science ®Google Scholar
• Fujiwara , H , Yamakuni , T , Ueno , M , Ishizuka , M , Shinkawa , T , Isobe , T and Ohizumi , Y . 2004 . IC101 induces apoptosis by Akt dephosphorylation via an inhibition of heat shock protein 90-ATP binding activity accompanied by preventing the interaction with Akt in L1210 cells . J. Pharmacol. Exp. Ther. , 310 : 1288 – 1295 .
   PubMed Web of Science ®Google Scholar
• Zhang , L , Fan , J , Vu , K , Hong , K , Brazidec , JYL , Shi , J , Biamonte , M , Busch , DJ , Lough , RE , Grecko , R , Ran , Y , Sensintaffar , JL , Kamal , A , Lundgren , K , Francis , J , Burrows , RM , Timony , GA , Ulm , EH , Kasibhatla , SR and Boehm , MF . 2006 . 7 ′-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors . J. Med. Chem. , 49 : 5352 – 5362 .
   PubMed Web of Science ®Google Scholar
• Brough , PA , Barril , X , Beswick , M , Dymock , BW , Drysdale , MJ , Wright , L , Grant , K , Massey , A , Surgenora , A and Workman , P . 2005 . 3-(5-chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone . Bioorg. Med. Chem. Lett. , 15 : 5197 – 5201 .
   PubMed Web of Science ®Google Scholar
• Barril , X , Brough , P , Drysdale , M , Hubbard , RE , Massey , A , Surgenor , A and Wright , L . 2005 . Structure-based discovery of a new class of Hsp90 inhibitors . Bioorg. Med. Chem. Lett. , 15 : 5187 – 5191 .
   PubMed Web of Science ®Google Scholar
• Dymock , BW , Barril , X , Brough , PA , Cansfield , JE , Massey , A , McDonald , E , Hubbard , RE , Surgenor , A , Roughley , SD , Webb , P , Workman , P , Wright , L and Drysdale , MJ . 2005 . Novel, Potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design . J. Med. Chem. , 48 : 4212 – 4215 .
   PubMed Web of Science ®Google Scholar
• Brough , PA , Aherne , W , Barril , X , Borgognoni , J , Boxall , K , Cansfield , JE , Cheung , KMJ , Collins , I , Davies , NGM , Drysdale , MJ , Dymock , B , Eccles , SA , Finch , H , Fink , A , Hayes , A , Howes , R , Hubbard , RE , James , K , Jordan , AM , Lockie , A , Martins , V , Massey , A , Matthews , TP , McDonald , E , Northfield , CJ , Pearl , LH , Prodromou , C , Ray , S , Raynaud , FI , Roughley , SD , Sharp , SY , Surgenor , A , Walmsley , DL , Webb , P , Wood , M , Workman , P and Wright , L . 2008 . 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer . J. Med. Chem. , 51 : 196 – 218 .
   PubMed Web of Science ®Google Scholar
• Barril , X , Beswick , MC , Collier , A , Drysdale , MJ , Dymock , BW , Fink , A , Grant , K , Howes , R , Jordan , AM , Massey , A , Surgenor , A , Wayne , J , Workmanb , P and Wright , L . 2006 . 4-Amino derivatives of the Hsp90 inhibitor CCT018159 . Bioorg. Med. Chem. Lett. , 16 : 2543 – 2548 .
   PubMed Web of Science ®Google Scholar
• Discovery studio 2.0 User Guide, Accelrys Inc., San Diego, CA
   Google Scholar
• Equbal , T , Silakari , O , Rambabub , G and Ravikumarb , M . 2007 . Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors . Bioorg. Med. Chem. Lett. , 17 : 1594 – 1600 .
   PubMed Web of Science ®Google Scholar
• GOLD, version 3.2; Cambridge Crystallographic Data Centre, Cambridge, UK
   Google Scholar
• ClustalW2. Available at http://www.ebi.ac.uk/Tools/clustalw2/index.html
   Google Scholar
• Liu , F , You , QD and Chen , YD . 2007 . Pharmacophore identification of KSP inhibitors . Bioorg. Med. Chem. Lett. , 17 : 722 – 726 .
   PubMed Web of Science ®Google Scholar
• Stebbins , CE , Russo , AA , Schneider , KC , Rosen , N , Hartl , FU and Pavletich , NP . 1997 . Crystal structure of an Hsp90–geldanamycin complex: targeting of a protein chaperone by an antitumor Agent . Cell , 89 : 239 – 250 .
   PubMed Web of Science ®Google Scholar
• UniProt. Available at http://www.uniprot.org
   Google Scholar